chromium has been researched along with Uterine Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, Q; Ma, RH; Tang, Y | 1 |
CARAMAZZA, G; CITTI, U; SANI, G | 1 |
Bakri, YN; Given, FT | 1 |
Blessing, J; Creasman, WT; Disaia, PJ; Johnston, W; Weed, JC; Wilkinson, RH | 1 |
Heath, R; Rosenman, J; Varia, M; Walton, L | 1 |
Clarke-Pearson, DL; Creasman, WT; Johnston, WW; Soper, JT; Sullivan, DC; Vergadoro, F | 1 |
6 other study(ies) available for chromium and Uterine Neoplasms
Article | Year |
---|---|
[Determination of trace element Cu, Zn, Mg, Cr in serum of women with barrenness and hysteromyoma disease].
Topics: Adult; Chromium; Copper; Female; Humans; Infertility, Female; Leiomyoma; Magnesium; Spectrophotometry, Atomic; Trace Elements; Uterine Neoplasms; Zinc | 2002 |
[Fluorochromicization of vaginal smears with acridine orange in the early diagnosis of cancer of the uterus].
Topics: Acridine Orange; Acridines; Chromium; Coloring Agents; Early Detection of Cancer; Female; Humans; Neoplasms; Staining and Labeling; Uterine Neoplasms; Vaginal Smears | 1962 |
Radioactivity in blood and urine following intraperitoneal instillation of chromic phosphate in patients with and without ascites.
Topics: Adult; Aged; Ascites; Brachytherapy; Chromium; Chromium Compounds; Female; Humans; Kinetics; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Uterine Neoplasms | 1984 |
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Topics: Adenocarcinoma; Ascitic Fluid; Chromium; Chromium Compounds; Female; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1981 |
Peritoneal fluid cytology in endometrial cancer: its significance and the role of chromic phosphate (32P) therapy.
Topics: Ascitic Fluid; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Hysterectomy; Injections, Intraperitoneal; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Neoplasms | 1988 |
Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
Topics: Adenocarcinoma; Brachytherapy; Catheters, Indwelling; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Hysterectomy; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Neoplasms | 1985 |